Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-12-15

Clinical Trial Update: Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders [Phase 2, Phase 3]

View source ↗

Summary

The document reports on a clinical trial evaluating whether melatonin can improve IVF/ICSI outcomes in women with poor ovarian response, across Phase 2 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: Assiut University | Conditions: In Vitro Fertilization, Poor Ovarian Response | Phase 2, Phase 3 | Status: UNKNOWN